Loading…
Apyx Medical Corporation is projected to rise to $5.08 by 2027, a +24% move from its current price of $4.10. APYX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $3.97 | $4.10 | $4.24 | +0.01% |
| Aug 5 | $3.91 | $4.10 | $4.30 | +0.01% |
| Aug 6 | $3.87 | $4.10 | $4.35 | +0.02% |
| Aug 7 | $3.84 | $4.10 | $4.38 | +0.03% |
| Aug 8 | $3.81 | $4.10 | $4.42 | +0.04% |
| Aug 9 | $3.78 | $4.10 | $4.45 | +0.04% |
| Aug 10 | $3.75 | $4.10 | $4.48 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.75 | $4.10 | $4.48 | +0.05% |
| Week 2 | $3.62 | $4.10 | $4.65 | +0.10% |
| Week 3 | $3.52 | $4.11 | $4.79 | +0.15% |
| Week 4 | $3.44 | $4.11 | $4.90 | +0.20% |
| Week 5 | $3.37 | $4.11 | $5.01 | +0.25% |
| Week 6 | $3.31 | $4.11 | $5.11 | +0.30% |
| Week 7 | $3.26 | $4.11 | $5.20 | +0.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Apyx Medical Corporation is an energy technology company that designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
Its helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
APYX is trading at $4.07 per share, with a market capitalization of $171.39M and a rank of 3682.
The stock’s technical picture shows a bullish tilt with RSI(14) at 40, and moving averages at $4.22 (50-day) and $3.77 (200-day). The price sits near a support level of $4.01 and faces resistance at $4.86.
The 30-day price range spans from $3.17 to $5.22, indicating broader volatility within a defined band. The forecast implies a rising price path over time, with the average price climbing to $9.21 by 2030 and to $58.35 by 2050, along with corresponding ROI figures of 126.3 and 1333.7 respectively.
A major floor 32.0% below — a decisive break under it would weaken the trend.
The nearest floor, 6.6% below — buyers have tended to step in here.
The nearest ceiling, 14.4% above — a clean break opens room to run.
A major ceiling 23.6% above — clearing it would confirm fresh momentum.
Key APYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of APYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.96 | Buy | $4.01 | Buy |
| MA 10 | $3.97 | Buy | $4.03 | Buy |
| MA 20 | $4.15 | Sell | $4.10 | Sell |
| MA 50 | $4.23 | Sell | $4.12 | Sell |
| MA 100 | $3.97 | Buy | $4.00 | Buy |
| MA 200 | $3.82 | Buy | $3.66 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.15 | Neutral |
| Stoch RSI (14) | 71.82 | Neutral |
| CCI (20) | -17.04 | Neutral |
| Williams %R (14) | -54.24 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -7.24 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 45.76 | Neutral |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -0.26 | Sell |
| Ultimate (7,14,28) | 58.41 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 4.01 | Buy |
| ADX (14) | 9.96 | Neutral |
| ATR (14) | 0.12 | Info |
The 30-day technical picture is bullish, with sentiment labeled BULLISH. RSI(14) sits at 40, and the price remains above the 200-day SMA of $3.77 but near the 50-day SMA of $4.22.
Support is identified at $4.01 and resistance at $4.86. The 30-day range runs from $3.17 to $5.22, highlighting potential movement within that window in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.79 | $4.10 | $5.29 | 0% | Neutral | |
| $3.97 | $5.08 | $6.92 | +24% | Bullish | |
| $3.76 | $4.99 | $7.11 | +22% | Bullish | |
| $4.34 | $5.93 | $8.75 | +45% | Bullish | |
| $5.88 | $8.24 | $12.50 | +101% | Bullish | |
| $6.52 | $9.35 | $14.56 | +128% | Bullish | |
| $7.31 | $10.73 | $17.08 | +162% | Bullish | |
| $7.48 | $11.21 | $18.20 | +173% | Bullish | |
| $7.32 | $11.19 | $18.50 | +173% | Bullish | |
| $8.38 | $13.06 | $21.97 | +218% | Bullish | |
| $12.67 | $21.58 | $38.99 | +426% | Bullish | |
| $22.44 | $44.72 | $89.49 | +991% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.79 | $4.10 | $4.89 | +0.00% |
| September 2026 | $3.49 | $4.15 | $5.10 | +1.33% |
| October 2026 | $3.44 | $4.13 | $5.14 | -0.67% |
| November 2026 | $3.33 | $4.03 | $5.07 | -2.36% |
| December 2026 | $3.42 | $4.16 | $5.29 | +3.35% |
Click any year to see its month-by-month APYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The APYX price prediction for 2026 points to an average of $4.10 (low $2.79, high $5.29) — a potential gain of 0% on today's $4.10. A consolidation phase looks the most probable path here.
In 2027, APYX is projected to trade between $3.97 and $6.92, averaging $5.08 — a potential gain of +24% from today's $4.10. That is up +24% on the projected 2026 average. Momentum favours further upside here.
Apyx Medical Corporation's 2028 outlook centres on $4.99, within a $3.76 to $7.11 range. That is -2% versus the projected 2027 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, APYX could reach as high as $8.75, with a base case around $5.93 and support toward $4.34 — roughly +45% from $4.10. Momentum favours further upside here.
Expect APYX to range from $5.88 to $12.50 through 2030. The $8.24 average target implies a +101% move from current prices. That is up +39% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The APYX price prediction for 2031 points to an average of $9.35 (low $6.52, high $14.56) — a potential gain of +128% on today's $4.10. Momentum favours further upside here.
In 2032, APYX is projected to trade between $7.31 and $17.08, averaging $10.73 — a potential gain of +162% from today's $4.10. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Apyx Medical Corporation's 2033 outlook centres on $11.21, within a $7.48 to $18.20 range. That is up +4% on the projected 2032 average. That marks a +173% change versus current levels. Momentum favours further upside here.
By 2034, APYX could reach as high as $18.50, with a base case around $11.19 and support toward $7.32 — roughly +173% from $4.10. Buyers look set to stay in control over this stretch.
Expect APYX to range from $8.38 to $21.97 through 2035. The $13.06 average target implies a +218% move from current prices. That is up +17% on the projected 2034 average. Momentum favours further upside here.
The APYX price prediction for 2040 points to an average of $21.58 (low $12.67, high $38.99) — a potential gain of +426% on today's $4.10. Buyers look set to stay in control over this stretch.
In 2050, APYX is projected to trade between $22.44 and $89.49, averaging $44.72 — a potential gain of +991% from today's $4.10. That is up +107% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in APYX today (≈ 243.902439 APYX) could be worth
$10,906.48
+$9,906.48 (+991%) by 2050 · US Dollar
Based on the average projected APYX price of $44.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in APYXwould be worth at today's price.
$1,000 invested in APYX on Jul 31, 2025 (≈ 523.560219 APYX) would be worth
$2,146.6
+$1,146.6 (+114.7%) today · 2.15× · US Dollar
Based on a APYX entry price of $1.91 vs. today's $4.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.92 | $1,045.92 | +4.6% |
| 1 month ago | $4.66 | $879.83 | -12.0% |
| 3 months ago | $3.06 | $1,339.87 | +34.0% |
| 6 months ago | $4.4 | $931.82 | -6.8% |
| 1 year ago | $1.91 | $2,146.6 | +114.7% |
| All time (5.0y) ago | $9.05 | $453.04 | -54.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our APYX forecast.
Our base-case forecast reaches $8.20 around 2030.
Implied market cap at $8.20: $345.3M
The multi-year forecast shows bullish momentum continuing through the horizon. In 2026 the average price is forecast at $4.07 with a min of $2.79 and a max of $5.48, and a neutral sentiment. By 2027 the average rises to $5.15 with a max of $7.16 and an ROI of 26.4, continuing a bullish trend through 2028 (avg $5.10, max $7.44, ROI 25.2).
In 2029, the average is forecast at $6.46 (min $4.61, max $9.80) with an ROI of 58.7, followed by 2030 with an average of $9.21 (min $6.38, max $14.42) and an ROI of 126.3. The path continues to 2031 (avg $10.46, max $16.82, ROI 156.9) and beyond, reaching 2040 (avg $25.67, max $48.51, ROI 530.7) and 2050 (avg $58.35, max $123.08, ROI 1333.7). All entries carry a bullish sentiment through these horizons.
These figures are estimates and not guarantees. They reflect modeled expectations for a range of outcomes and should be interpreted with appropriate caution given market uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $9.21 with a min of $6.38 and a max of $14.42, and an ROI of 126.3. The sentiment is BULLISH.
The forecast indicates bullish sentiment from 2027 onward, with notable upside. For example, 2027 average is $5.15 (ROI 26.4), 2028 average $5.10 (ROI 25.2), 2029 average $6.46 (ROI 58.7), 2030 average $9.21 (ROI 126.3), 2040 average $25.67 (ROI 530.7), and 2050 average $58.35 (ROI 1333.7). These are estimates, not guarantees.
No. The 2030 max forecast is $14.42, while the 2031 max forecast is $16.82. Therefore, $15 is not projected for 2030 but could occur later in the forecast horizon.
The current price is $4.07 and the market capitalization is $171.39M.
The 30-day range is from $3.17 to $5.22.
Apyx Medical Corporation Community Discussion
0Share your Apyx Medical Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.